Drug Trial Radar · NCT07819136
REC-7735 in Participants With Solid Tumors
Last checked: Nov 19, 2026Latest source record: Sep 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
90
Planned (sponsor's estimate)
Start
Sep 2026
Primary completion
Jan 2031
Study completion Jan 2031
Sponsor
- Lead sponsor
- Recursion Pharmaceuticals Inc.Industry
- Sponsor type
- Industry
- First posted
- Sep 14, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study is designed to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary anti-tumor activity of REC-7735 in participants with unresectable, locally advanced, or metastatic PIK3CA-H1047R mutated solid tumors.
Conditions
- Solid Tumors
Interventions
REC-7735Drug
Oral
Primary outcomes
What the sponsor says the trial is designed to measure.
- Phase 1A: Number of Participants With Dose-limiting Toxicities (DLTs)Time frame: 28 days
- Number of Participants With Treatment-emergent Adverse Events (TEAEs)Time frame: Up to 2 years
- Phase 1B: Objective Response Rate (ORR) According to Standard Response Evaluation Criteria in Solid Tumors (RECIST) 1.1Time frame: Up to 2 years
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
START Midwest
Grand Rapids, Michigan · Recruiting
NEXT Oncology - Dallas
Irving, Texas · Recruiting
NEXT Virginia
Fairfax, Virginia · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.